Rebamipide during chronic gastritis: <i>H. pylori</i> eradication therapy and restoration of gastric mucosa barrier function
Аim: to present evidence justifying prescription of rebamipide during chronic gastritis.Key points. Experimental and clinical studies have demonstrated that rebamipide increases concentration of prostaglandins (prostaglandin E2 and prostacyclin) and production of mucin, manages inflammation and oxid...
Saved in:
Main Authors: | Т. L. Lapina, V. T. Ivashkin |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Gastro LLC
2024-01-01
|
Series: | Российский журнал гастроэнтерологии, гепатологии, колопроктологии |
Subjects: | |
Online Access: | https://www.gastro-j.ru/jour/article/view/940 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Consensus Meeting of European Society of Neurogastroenterology and Motility on Functional Dyspepsia (2020): Have We Dotted All the I’s?
by: A. A. Sheptulin, et al.
Published: (2021-06-01) -
H. pylori-Associated Gastritis, Gastritis after H. pylori Eradication and H. pylori-Negative Gastritis: Algorithm of Diagnosis and Treatment (Literature Review and Resolution of the Expert Panel of the Russian Gastroenterological Association)
by: V. T. Ivashkin, et al.
Published: (2024-08-01) -
Results of long-term follow-up of patients with chronic gastritis after <i>H. pylori</i> eradication
by: T. L. Lapina, et al.
Published: (2015-09-01) -
Ultrasound Features of <i>Helicobacter pylori</i>-Related Gastritis
by: Fulvia Terracciano, et al.
Published: (2024-12-01) -
Clinical Recommendations of Russian Gastroenterological Association and RENDO Endoscopic Society on Diagnosis and Treatment of Gastritis and Duodenitis
by: V. T. Ivashkin, et al.
Published: (2021-12-01)